Semaglutide 10mg
Semaglutide is a long-acting GLP-1 (Glucagon-Like Peptide-1) receptor agonist with approximately 94% structural homology to endogenous GLP-1, engineered with an albumin-binding C18 fatty acid side chain that extends its half-life to approximately 7 days. FDA-approved as Ozempic and Wegovy, it represents one of the most clinically relevant metabolic peptides currently available for research.
Research has extensively characterized semaglutide's effects on glucose-dependent insulin secretion, gastric emptying, appetite suppression via hypothalamic pathways, beta-cell protection, cardiovascular risk reduction, and adipose tissue mobilization.
Specifications: 10mg lyophilized powder | Purity ≥99% (HPLC) | MW 4113.6 g/mol | Store at −20°C
For Research Use Only. Not for human or veterinary use. This product is intended solely for in vitro and laboratory research. Not approved by the FDA. Not a drug, food, or cosmetic. Keep out of reach of children.
